SCHEMBL7249259

SCHEMBL7249259

Cn1c(CCc2ccc(C#N)cc2)nc2cc(C(=O)NCCC(c3ccccc3)c3ccccc3)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.48
HDAC6 Q9UBN7 4/20 0.46
HDAC1 Q13547 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46
GAA P10253 1/20 0.45
POLB P06746 1/20 0.45
F2 P00734 1/20 0.45
HAT1 O14929 2/20 0.45
EP300 Q09472 2/20 0.45
BCHE P06276 1/20 0.44
CNR2 P34972 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CYP2J2 P51589 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7246014 0.89 HDAC1 (0.50) HDAC6HDAC1ALDH1A1HSD17B10GAA
Hydrochloric Acid SCHEMBL7251457 0.88 F2 (0.48) HDAC6HDAC1ALDH1A1HSD17B10GAA
SCHEMBL7244362 0.87 HDAC6 (0.54) HDAC6HDAC1ALDH1A1HSD17B10GAA
SCHEMBL7251622 0.87 F2 (0.60) HDAC6HDAC1ALDH1A1HSD17B10GAA
Hydrochloric Acid SCHEMBL7246548 0.86 F2 (0.59) HDAC6HDAC1ALDH1A1HSD17B10GAA
SCHEMBL7252107 0.82 F2 (0.49) HDAC6HDAC1F2HAT1EP300
SCHEMBL8029864 0.82 ALDH1A1 (0.49) HDAC6HDAC1ALDH1A1HSD17B10BCHE
SCHEMBL6486632 0.81 F2 (0.50) HDAC6HDAC1ALDH1A1HSD17B10GAA
Hydrochloric Acid SCHEMBL7244675 0.80 F2 (0.49) HDAC6HDAC1ALDH1A1HSD17B10GAA
SCHEMBL6475543 0.79 KDM4E (0.48) HDAC6HDAC1F2CNR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6512000-B1 Aminocarbonyl- substituted benzimidazole derivatives for the treatment of diseases in which inhibition of tryptase is of therapeutic such as for treating an inflammatory or allergic disease BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-01-28 US disclosed